Dupont Capital Management Corp reduced its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 55.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 37,562 shares of the company's stock after selling 46,958 shares during the quarter. Dupont Capital Management Corp's holdings in Procter & Gamble were worth $5,984,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of PG. Brighton Jones LLC lifted its holdings in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock valued at $6,717,000 after buying an additional 13,617 shares during the period. Taylor Financial Group Inc. increased its stake in Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock valued at $493,000 after purchasing an additional 277 shares in the last quarter. GAMMA Investing LLC increased its stake in Procter & Gamble by 22.4% in the 1st quarter. GAMMA Investing LLC now owns 46,658 shares of the company's stock valued at $7,951,000 after purchasing an additional 8,537 shares in the last quarter. Summit Wealth Group LLC increased its stake in Procter & Gamble by 11.2% in the 1st quarter. Summit Wealth Group LLC now owns 7,437 shares of the company's stock valued at $1,267,000 after purchasing an additional 752 shares in the last quarter. Finally, North Point Portfolio Managers Corp OH increased its stake in Procter & Gamble by 138.1% in the 1st quarter. North Point Portfolio Managers Corp OH now owns 5,871 shares of the company's stock valued at $1,001,000 after purchasing an additional 3,405 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Procter & Gamble
In other news, CFO Andre Schulten sold 4,252 shares of the firm's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $647,281.96. Following the sale, the chief financial officer owned 53,992 shares in the company, valued at $8,219,202.16. This trade represents a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm's stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This trade represents a 7.83% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is currently owned by insiders.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on PG. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. UBS Group dropped their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Wells Fargo & Company dropped their price objective on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research note on Thursday, September 25th. Finally, JPMorgan Chase & Co. dropped their price objective on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research note on Friday, October 10th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of "Moderate Buy" and a consensus price target of $171.68.
Check Out Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Stock Performance
Procter & Gamble stock opened at $151.98 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. The stock has a fifty day moving average of $154.86 and a two-hundred day moving average of $158.59. The company has a market capitalization of $355.72 billion, a price-to-earnings ratio of 23.35, a PEG ratio of 4.02 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $146.96 and a fifty-two week high of $180.43.
Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the business posted $1.40 earnings per share. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. The ex-dividend date is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble's dividend payout ratio (DPR) is 64.82%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
